Clinical Trials in New York

Showing 8741-8760 of 19,464 trials

MRI and PET to Assess Pembrolizumab Response

NCT02591654

The purpose of this study is to test two imaging techniques, one called whole body (WB) diffusion weighted (DWI) magnetic resonance imaging (MRI) (WB-DWI MRI), and another called Fluorine-18 3'-deoxy-3'-fluorothymidine positron emission tomography (PET) (F-18-FLT PET). The goal is to see whether these imaging techniques would allow the study doctors to see changes in the size of a tumor earlier for patients with metastatic melanoma receiving Pembrolizumab (MK-3475).

Malignant Melanoma, Metastatic

Columbia University6 participantsStarted Oct 2015

New York, New York, United States

TERMINATEDNA< 1 mile

Trial on Endovascular Aneurysm Management

NCT00537134

The management of patients with unruptured aneurysms is controversial. Patients with unruptured aneurysms may suffer intracranial hemorrhage, but the incidence of this event is still debated. Endovascular treatment can prevent rupture, but involves immediate risks; furthermore, successful treatment does not eliminate all risks. A randomized trial may be the best way to demonstrate the potential benefits of endovascular over conservative management of unruptured aneurysms.

Brain Aneurysm

Centre hospitalier de l'Université de Montréal (CHUM)80 participantsStarted Apr 2006

Phoenix, Arizona, United States • Boston, Massachusetts, United States • Brooklyn, New York, United States +6 more locations

MRI and PET to Assess Pembrolizumab Response

Trial on Endovascular Aneurysm Management

Find Trials by Condition in New York

Predicting Favorable Outcomes in Hospitalized Covid-19 Patients

REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects

Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease

Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma

A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood Transfusion

Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals

Integrated Stepped Care for Unhealthy Alcohol Use in HIV

A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma

Addition of X4P-001 to Nivolumab Treatment in Participants With Renal Cell Carcinoma

A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer

A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants

Long-term Follow-up Durability (Efficacy) Study of EN3835 for the Treatment of AC of the Shoulder (Frozen Shoulder)

Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma

OLAParib COmbinations

Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OI

A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants With Major Depressive Disorder (MDD) From 7 to 18 Years of Age

A Rollover Study to Provide Continued Treatment With Eltrombopag